Association between antibiotic use during early life and early‐onset colorectal cancer risk overall and according to polygenic risk and FUT2 genotypes

Fangyuan Jiang,Daniel Boakye,Jing Sun,Lijuan Wang,Lili Yu,Xuan Zhou,Jianhui Zhao,Zilong Bian,Peige Song,Yazhou He,Yingshuang Zhu,Jie Chen,Shuai Yuan,Mingyang Song,Susanna C. Larsson,Edward L Giovannucci,Evropi Theodoratou,Kefeng Ding,Xue Li
DOI: https://doi.org/10.1002/ijc.34648
2023-07-30
International Journal of Cancer
Abstract:What's new? Early‐onset colorectal cancer is on the rise worldwide, possibly driven by exposure to risk factors in childhood. Long‐term or recurrent use of antibiotics, for instance, could cause long‐lasting changes in the gut microbiota that lead to cancer susceptibility. Here, the authors investigated the association between antibiotics use and cancer risk, both overall and according to certain genetic factors. They found that long‐term or recurrent antibiotic use increased the risk of early‐onset CRC and adenomas, with a stronger effect in people with a particular variant of the gut microbiota regulatory gene, Fucosyltransferase 2 (FUT2). Early‐onset colorectal cancer (EOCRC) has been increasing worldwide. Potential risk factors may have occurred in childhood or adolescence. We investigated the associations between early‐life factors and EOCRC risk, with a particular focus on long‐term or recurrent antibiotic use (LRAU) and its interaction with genetic factors. Data on the UK Biobank participants recruited between 2006 and 2010 and followed up to February 2022 were used. We used logistic regression to estimate adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) of the associations between LRAU during early life and EOCRC risk overall and by polygenic risk score (constructed by 127 CRC‐related genetic variants) and Fucosyltransferase 2 (FUT2), a gut microbiota regulatory gene. We also assessed the associations for early‐onset colorectal adenomas, as precursor lesion of CRC, to examine the effect of LRAU during early‐life and genetic factors on colorectal carcinogenesis. A total of 113 256 participants were included in the analysis, with 165 EOCRC cases and 719 EOCRA cases. LRAU was nominally associated with increased risk of early‐onset CRC (OR = 1.48, 95% CI = 1.01‐2.17, P = .046) and adenomas (OR = 1.40, 95% CI = 1.17‐1.68, P
oncology
What problem does this paper attempt to address?